Human histiocytic lymphoma cells (U-937)

Human histiocytic lymphoma cells (U-937) are a vital resource in cancer research particularly for studying the biology of lymphomas and the effectiveness of novel therapeutic agents; their preservation in dry ice allows for safe and reliable transport for experimental applications

These cells serve as a model for monocyte differentiation and immune response studies facilitating understanding of how these processes affect hematologic malignancies thereby contributing to the development of targeted cancer treatments

In laboratory settings the suspended growth of U-937 cells in RPMI-1640 supplemented with 10% FBS provides an optimal environment for examining cellular behavior proliferation and response to various treatments essential for advancing cancer research

Furthermore the application of U-937 cells in drug screening processes enables researchers to assess the cytotoxicity and efficacy of potential anti-cancer compounds making them a cornerstone in the development of innovative cancer therapies

With a high viability rate post-transport these cells not only provide consistency in experimental outcomes but also significantly contribute to the broader understanding of tumor biology and the advancement of personalized medicine